Table 1.
SSRI (n=103) | CBT plus SSRI (n=105) | |
---|---|---|
Female | 75 (73) | 79 (75) |
Median (range) age (years) | 14 (11-17) | 14 (11-17) |
Study centre: | ||
Manchester | 74 (72) | 75 (71) |
Cambridge | 29 (28) | 30 (29) |
Behavioural disorder | 30 (29) | 33 (31) |
CGAS >40 | 58 (56) | 49 (47) |
Mean (SD) depressive symptoms | 6.6 (1.5) | 6.4 (1.4) |
Comorbid diagnosis: | ||
Social phobia | 49 (48) | 43 (41) |
Obsessive compulsive disorder | 37 (36) | 42 (40) |
Post-traumatic stress disorder | 36 (35) | 42 (40) |
Agoraphobia | 29 (28) | 36 (34) |
Separation anxiety disorder | 28 (27) | 31 (29) |
Specific phobia | 22 (22) | 25 (26) |
Conduct disorder | 17 (17) | 18 (17) |
Panic disorder (without agoraphobia) | 14 (14) | 21 (20) |
Oppositional defiance disorder | 13 (13) | 17 (16) |
Generalised anxiety disorder | 13 (13) | 19 (18) |
Panic disorder (with agoraphobia) | 13 (13) | 20 (19) |
ADHD | 6 (6) | 5 (5) |
Bulimia nervosa | 4 (4) | 8 (8) |
Alcohol abuse | 4 (4) | 1 (1) |
Transient tic disorder | 3 (3) | 2 (2) |
Tourette's syndrome | 2 (2) | 2 (2) |
Alcohol dependence | 2 (2) | 1 (1) |
Chronic motor or vocal tic disorder | 1 (1) | 2 (2) |
Anorexia nervosa | 0 | 1 (1) |
Encopresis | 0 | 1 (1) |
Enuresis | 0 | 1 (1) |
Dysthymia | 0 | 1 (1) |
CGAS=children's global assessment scale; ADHD=attention deficit hyperactivity disorder.